Sabby Management »

C3is shares owned by Sabby Management

Quarter-by-quarter ownership of C3is (CISS) shares owned by Sabby Management from 13F filings

Historical chart of Sabby Management investment in C3is

Tip: Access up to 7 years of quarterly data

All positions including C3is held by Sabby Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in C3is by Sabby Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $4.7k 10k 0.46

More positions owned by Sabby Management

Ishares Tr Etf Put Option
SPDR S&P 500 Etf Put Option
Ishares Tr Etf (IWM)
SPDR S&P 500 Etf (SPY)
Apricus Biosciences
Tuanche Ads
Recon Technology Cl A (RCON)
Biora Therapeutics Ord (BIOR)
Akari Therapeutics Adr
Tonix Pharmaceuticals Hldg (TNXP)
Reviva Pharmaceutcls Hldgs I Put Option
Reviva Pharmaceutcls Hldgs I Call Option
Nisun Intl Ent Dvpmt Gp SHS (NISN)
Integrity Applications (GCTK)
Dogness Intl Corp Cl A

View all positions for Sabby Management

Top funds holding C3is

Jane Street
Citadel Advisors
UBS Group
Hrt Financial
Tower Research Capital
Jpmorgan Chase & Co
TowerView
Resources Investment Advisors
Estabrook Capital Management
Group One Trading
Barclays
Moisand Fitzgerald Tamayo

View all funds holding C3is